Carter Robert Ross sold TOI

January 2, 2026 · Form 4 insider transaction

Carter Robert Ross sold 247 shares of Starling Oncology Inc at $3.56 per share, a transaction worth $879.32. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
247
Price
$3.56
Total value
$879.32
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after235,122
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The reporting person used the proceeds of this sale to cover tax liabilities arising from the vesting of an RSU award on January 1, 2026.

View the original Form 4 on SEC EDGAR